239 related articles for article (PubMed ID: 25770474)
1. Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements.
Delitto D; Pham K; Vlada AC; Sarosi GA; Thomas RM; Behrns KE; Liu C; Hughes SJ; Wallet SM; Trevino JG
Am J Pathol; 2015 May; 185(5):1297-303. PubMed ID: 25770474
[TBL] [Abstract][Full Text] [Related]
2. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
3. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
4. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
[TBL] [Abstract][Full Text] [Related]
6. Histological advantages of the tumor graft: a murine model involving transplantation of human pancreatic cancer tissue fragments.
Akashi Y; Oda T; Ohara Y; Miyamoto R; Hashimoto S; Enomoto T; Yamada K; Kobayashi A; Fukunaga K; Ohkochi N
Pancreas; 2013 Nov; 42(8):1275-82. PubMed ID: 24152953
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
8. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
[TBL] [Abstract][Full Text] [Related]
9. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
10. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
11. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
12. Preclinical models of pancreatic ductal adenocarcinoma.
Krempley BD; Yu KH
Chin Clin Oncol; 2017 Jun; 6(3):25. PubMed ID: 28705002
[TBL] [Abstract][Full Text] [Related]
13. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
[TBL] [Abstract][Full Text] [Related]
16. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success.
Eguchi S; Kimura K; Kageyama K; Tani N; Tanaka R; Nishio K; Shinkawa H; Ohira GO; Amano R; Tanaka S; Yamamoto A; Takemura S; Yashiro M; Kubo S
Anticancer Res; 2022 May; 42(5):2395-2404. PubMed ID: 35489770
[TBL] [Abstract][Full Text] [Related]
17. Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.
Sharma R; Buitrago S; Pitoniak R; Gibbs JF; Curtin L; Seshadri M; Repasky EA; Hylander BL
Pancreas; 2014 Mar; 43(2):298-305. PubMed ID: 24518511
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
Mohammad RM; Dugan MC; Mohamed AN; Almatchy VP; Flake TM; Dergham ST; Shields AF; Al-Katib AA; Vaitkevicius VK; Sarkar FH
Pancreas; 1998 Jan; 16(1):19-25. PubMed ID: 9436858
[TBL] [Abstract][Full Text] [Related]
19. Establishment and long-term xenografting of human pancreatic carcinomas in immunosuppressed mice: changes and stability in morphology, DNA ploidy and proliferation activity.
Bocsi J; Zalatnai A
J Cancer Res Clin Oncol; 1999; 125(1):9-19. PubMed ID: 10037272
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of nude mouse models of patient-derived lung cancer xenograft].
Pan H; Ma Z; Mao L
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):571-4. PubMed ID: 25430021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
